Trends and Outcomes in Lung Transplantation in Patients with and without Idiopathic Pulmonary Fibrosis in Spain during the Period 2016-2020

被引:0
|
作者
Ballesteros, Belen Lopez-Muniz [1 ]
Lopez-de-Andres, Ana [2 ]
Jimenez-Garcia, Rodrigo [2 ]
Zamorano-Leon, Jose J. [2 ]
Carabantes-Alarcon, David [2 ]
Cuadrado-Corrales, Natividad [2 ]
Del-Barrio, Jose L. [3 ]
Perez-Farinos, Napoleon [4 ]
De Miguel-Diez, Javier [5 ]
机构
[1] Hosp Univ Infanta Leonor, Resp Dept, Madrid 28031, Spain
[2] Univ Complutense Madrid, Fac Med, Dept Publ Hlth & Maternal & Child Hlth, Madrid 28040, Spain
[3] Univ Rey Juan Carlos, Hlth Sci Fac, Prevent Med & Publ Hlth Teaching & Res Unit, Alcorcon 28933, Spain
[4] Univ Malaga, Sch Med, Inst Invest Biomed Malaga IBIMA, Epi PHAAN Res Grp, Malaga 29071, Spain
[5] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Fac Med,Resp Dept, Madrid 28040, Spain
关键词
lung transplant; idiopathic pulmonary fibrosis; incidence; complications; in-hospital mortality; COVID-19; pandemic; INTERNATIONAL SOCIETY; RISK-FACTORS; ADULT LUNG; GRAFT DYSFUNCTION; ALLOCATION SCORE; REGISTRY; HEART; FOCUS; MORTALITY; SURVIVAL;
D O I
10.3390/healthcare11111534
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
(1) Background: This paper aims to assess temporal trends (2016-2020) in incidence, patient's characteristics, complications, length of hospital stay (LOHS) and in-hospital mortality (IHM) among patients with and without idiopathic pulmonary fibrosis (IPF) undergoing lung transplantation (LTx). We also analyse the effect of the COVID-19 pandemic on LTx in these populations. (2) Methods: A retrospective, population-based observational study was conducted using the Spanish National Hospital Discharge Database. Multivariable adjustment was conducted with logistic regression to analyse the IHM. (3) Results: We identified 1777 admissions for LTx during the study period, of which 573 (32.2%) were performed in patients with IPF. The number of hospital admissions for LTx rose from 2016 to 2020, both in patients with and without IPF, but a marked reduction was observed from year 2019 to year 2020. Over time, the proportion of single LTx decreased and bilateral LTx increased significantly in both groups. The incidence of LTx complications increased significantly over time along with the increase in the incidence of IPF. No significant differences in the incidence of complications or in the IHM between patients with and without IPF were found. Suffering any complication of the LTx and pulmonary hypertension were conditions positively associated with IHM in patients with and without IPF. The IHM remained stable from 2016 to 2020 in both study populations and was not affected by the COVID pandemic. (4) Conclusions: Patients with IPF account for almost a third of all lung transplants. The number of LTx increased over time in patients with and without IPF, but a marked reduction was observed from 2019 to 2020. Although the proportion of LTx complications increased significantly over time in both groups, the IHM did not change. IPF was not associated with increased complications or IHM after LTx.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Gastroesophageal reflux in idiopathic pulmonary fibrosis patients awaiting lung transplantation
    Pashinsky, Yevgenia
    Padilla, Maria L.
    Goldstein, Eric S.
    Jaffin, Barry W.
    GASTROENTEROLOGY, 2008, 134 (04) : A171 - A171
  • [22] National Trends in Prevalence of Depression in Men and Women with Chronic Obstructive Pulmonary Disease Hospitalized in Spain, 2016-2020
    de Miguel-Diez, Javier
    Lopez-de-Andres, Ana
    Jimenez-Garcia, Rodrigo
    de Miguel-Yanes, Jose M.
    Hernandez-Barrera, Valentin
    Carabantes-Alarcon, David
    Zamorano-Leon, Jose J.
    Noriega, Concepcion
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
  • [23] Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes
    Akira Iyoda
    Yoko Azuma
    Susumu Sakamoto
    Sakae Homma
    Atsushi Sano
    Surgery Today, 2022, 52 : 736 - 744
  • [24] Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes
    Iyoda, Akira
    Azuma, Yoko
    Sakamoto, Susumu
    Homma, Sakae
    Sano, Atsushi
    SURGERY TODAY, 2022, 52 (05) : 736 - 744
  • [25] NATIONAL TRENDS AND INPATIENT OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION: A 5-YEAR ANALYSIS OF NATIONAL INPATIENT SAMPLE (2016-2020)
    Pandey, Mandvi
    Test, Victor J.
    CHEST, 2024, 166 (04) : 6524A - 6524A
  • [26] Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients
    Kim, Ho Cheol
    Lee, Seonjeong
    Song, Jin Woo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients
    Ho Cheol Kim
    Seonjeong Lee
    Jin Woo Song
    Scientific Reports, 11
  • [28] Pulmonary rehabilitation improves survival in patients with idiopathic pulmonary fibrosis undergoing lung transplantation
    Florian, Juliessa
    Watte, Guilherme
    Zimermann Teixeira, Paulo Jose
    Altmayer, Stephan
    Schio, Sadi Marcelo
    Sanchez, Leticia Beatriz
    Nascimento, Douglas Zaione
    Camargo, Spencer Marcantonio
    Perin, Fabiola Adelia
    Camargo, Jose de Jesus
    Felicetti, Jose Carlos
    Moreira, Jose da Silva
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [29] Influence of Pulmonary Hypertension on Patients with Advanced Idiopathic Pulmonary Fibrosis Prior to Lung Transplantation
    Mao, Wenjun
    Chen, Jingyu
    TRANSPLANTATION, 2017, 101 (05) : S47 - S47
  • [30] Pulmonary rehabilitation improves survival in patients with idiopathic pulmonary fibrosis undergoing lung transplantation
    Juliessa Florian
    Guilherme Watte
    Paulo José Zimermann Teixeira
    Stephan Altmayer
    Sadi Marcelo Schio
    Letícia Beatriz Sanchez
    Douglas Zaione Nascimento
    Spencer Marcantonio Camargo
    Fabiola Adélia Perin
    José de Jesus Camargo
    José Carlos Felicetti
    José da Silva Moreira
    Scientific Reports, 9